{"id":5027,"date":"2021-06-22T04:32:50","date_gmt":"2021-06-22T04:32:50","guid":{"rendered":"https:\/\/blogs.sld.cu\/oserranob\/?p=5027"},"modified":"2021-06-23T14:07:13","modified_gmt":"2021-06-23T14:07:13","slug":"transcriptomica-identifica-farmacos-con-accion-anti-sars-cov-2","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2021\/06\/22\/transcriptomica-identifica-farmacos-con-accion-anti-sars-cov-2\/","title":{"rendered":"Transcript\u00f3mica identifica f\u00e1rmacos con acci\u00f3n anti-SARS-CoV-2"},"content":{"rendered":"<p style=\"text-align: justify\"><a href=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2021\/06\/Transcriptomics1.png\"><img loading=\"lazy\" class=\"alignleft wp-image-5038 size-full\" style=\"border-width: 1px;margin: 5px\" title=\"(c) Le BL, et al. Scientific Reports 2021.\" src=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2021\/06\/Transcriptomics1.png\" alt=\"Transcriptomics1\" width=\"85\" height=\"107\" \/><\/a>El haloperidol y la clofazimina est\u00e1n entre los 11 medicamentos con actividad antiviral frente a SARS-CoV-2, a partir de las diferencias en los patrones de expresi\u00f3n g\u00e9nica entre muestras de infectados y controles. El reporte aparece en Le BL, Andreoletti G, Oskotsky T, Vallejo-Gracia A, Rosales R, Yu K, et al. <a title=\"Texto completo en ingl\u00e9s\" href=\"https:\/\/www.nature.com\/articles\/s41598-021-91625-1\" target=\"_blank\">Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19<\/a>. Scientific Reports 2021;11:12310.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El haloperidol y la clofazimina est\u00e1n entre los 11 medicamentos con actividad antiviral frente a SARS-CoV-2, a partir de las diferencias en los patrones de expresi\u00f3n g\u00e9nica entre muestras de infectados y controles. El reporte aparece en Le BL, Andreoletti G, Oskotsky T, Vallejo-Gracia A, Rosales R, Yu K, et al. Transcriptomics-based drug repositioning pipeline [&hellip;]<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[8,28,39],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/5027"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=5027"}],"version-history":[{"count":3,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/5027\/revisions"}],"predecessor-version":[{"id":5040,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/5027\/revisions\/5040"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=5027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=5027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=5027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}